IgE-Mediated Reaction to Metamizole: Evaluation of a Patient with Severe Anaphylaxis

Area of Science:

• Pharmacology
• Clinical Medicine
• Drug Safety

Background:

• Metamizole is a non-steroidal anti-inflammatory drug (NSAID) used for pain and fever.
• Known adverse reactions include systemic effects and bone marrow suppression.
• Parenteral administration routes require careful monitoring.

Observation:

• A case of systemic reaction following parenteral metamizole (Novalgin®) administration is presented.
• The reaction occurred after the application of the drug.
• Detailed clinical observations of the reaction were recorded.

Findings:

• The study focuses on a specific instance of systemic reaction to metamizole.
• Discussion includes the potential mechanisms contributing to the observed reaction.
• This highlights the importance of recognizing and understanding metamizole-induced adverse events.

Implications:

• Understanding the mechanisms of metamizole-induced systemic reactions is crucial for patient safety.
• This case report contributes to the pharmacovigilance of metamizole.
• Clinical practitioners should be aware of potential severe adverse reactions to parenteral metamizole.